to fluoxetine as a single agent, and dose was gradually hiked to 60 mg. Now, she is asymptomatic for the past 15 months.
INTRODUCTION
Galactorrhea is an adverse effect, experienced commonly with antipsychotics, through their dopamine-blocking action and consequent disinhibition of prolactin (PRL) secretion. [1] Galactorrhea with antidepressants is less commonly reported in the medical literature. Here, we present series of 3 cases, who developed galactorrhea with combination of antidepressants.
Case 3
A 17-year-old girl presented with complaints of episodic shortness of breath, anxiety, and sleep disturbance for about 25 days. Initially, she was prescribed escitalopram 20 mg/day and sertraline 50 mg/day by a physician, and on the 9 th day, she reported secretions from the breasts. She was diagnosed as somatoform autonomic dysfunction of respiratory system (F45.33) with galactorrhea. Her serum PRL level was raised (164.4 ng/ml). Then, she was kept on clonazepam 1 mg/day along with psychotherapy sessions. After stopping the medicines, the discharge stopped completely in 10 days. At present, the patient is asymptomatic for the past 3 months and not receiving any psychotropic medications.
DISCUSSION
The peculiarity of index case series is occurrence of galactorrhea with combination of antidepressants, and serum PRL levels were significantly raised in all three patients. Recurrence of galactorrhea was not seen with monotherapy of selective serotonin reuptake inhibitor (SSRI) (Case 1), switching on bupropion (Case 2), and stoppage of SSRIs (Case 3).
Here, the first case developed galactorrhea with hyperprolactinemia with the combination of fluoxetine 40 mg and amitriptyline 25 mg (PRL -333 ng/ml). This is possibly second report of galactorrhea with combination of SSRIs and tricyclic antidepressants in India. Unlike the previous case, [2] our patient had significantly raised PRL levels. Later, even on high dose of fluoxetine, the patient is symptom free as well as euthymic.
In the second case, galactorrhea was developed initially with the combination of SSRI and SNRI (venlafaxine 150 mg and fluoxetine 20 mg) with hyperprolactinemia (PRL >200 ng/ml) and later with dosulepin 225 mg with hyperprolactinemia (PRL -170 ng/ml). Similar cases of fluoxetine-induced [3] and venlafaxine-induced [4] galactorrhea with hyperprolactinemia were reported in literature. Only one case of dosulepin (dothiepin)-induced galactorrhea was reported in literature [5] before index case.
In the third case, again, galactorrhea was developed with the combination of two SSRIs (escitalopram 20 mg/ day and sertraline 50 mg/day). In index case, PRL level was raised significantly while earlier reported cases of sertraline-induced [6] and escitalopram-induced [7] galactorrhea did not investigate the same or had normal PRL level.
Galactorrhea is a rare but unwanted side effect of antidepressants, which is emotionally traumatizing especially to young unmarried women, so clinician needs to be aware of this unusual side effect for comprehensive and timely management.
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